Graypoint LLC Purchases 116 Shares of Humana Inc. (NYSE:HUM)

Graypoint LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 17.1% during the fourth quarter, HoldingsChannel reports. The fund owned 793 shares of the insurance provider’s stock after buying an additional 116 shares during the quarter. Graypoint LLC’s holdings in Humana were worth $363,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of HUM. Gradient Investments LLC grew its holdings in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares during the last quarter. Sunbelt Securities Inc. bought a new stake in shares of Humana in the 1st quarter valued at about $28,000. Householder Group Estate & Retirement Specialist LLC acquired a new stake in shares of Humana in the third quarter valued at about $39,000. Nvwm LLC raised its position in shares of Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after acquiring an additional 25 shares during the last quarter. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of Humana in the fourth quarter worth approximately $55,000. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $312.59 on Monday. Humana Inc. has a 12 month low of $299.23 and a 12 month high of $541.21. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The stock has a market cap of $37.71 billion, a P/E ratio of 15.77, a P/E/G ratio of 1.83 and a beta of 0.45. The company has a 50 day moving average of $347.21 and a 200 day moving average of $428.90.

Humana (NYSE:HUM) last released its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The firm had revenue of $26.46 billion during the quarter, compared to the consensus estimate of $25.47 billion. During the same period in the previous year, the company posted $1.62 EPS. The company’s revenue for the quarter was up 17.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a dividend of $0.885 per share. The ex-dividend date is Wednesday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. Humana’s dividend payout ratio (DPR) is presently 17.86%.

Wall Street Analyst Weigh In

Several research firms have issued reports on HUM. Truist Financial restated a “hold” rating and set a $550.00 price target on shares of Humana in a report on Friday, January 19th. Stephens reduced their price objective on Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research note on Friday, January 26th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $391.00 target price on shares of Humana in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating and decreased their target price for the stock from $595.00 to $360.00 in a research report on Thursday, January 25th. Finally, Bank of America reiterated a “neutral” rating and set a $342.00 price target (down previously from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $465.42.

Insider Transactions at Humana

In related news, Director Jorge S. Mesquita bought 545 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.29% of the stock is owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.